Revolution Medicines, shared on LinkedIn:
“Some of the hardest problems in medicine demand a different way of thinking.
For decades, directly targeting RAS was considered beyond the reach of medicine. We saw a different possibility. It required challenging long-standing assumptions, following what the science revealed and asking new questions of complex biology.
We follow the science. We push beyond convention. We act with urgency because the stakes for patients demand it.
See what drives Revolution Medicines.”
Other articles about Revolution Medicines on OncoDaily.